Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Healthy men help track cancer Drug's journey through the body

NCT ID NCT05109832

First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 31 times

Summary

This study looked at how a drug called IMP4297, being developed for solid tumors, is absorbed, broken down, and removed from the body. Six healthy Chinese men took a single dose, and researchers measured the drug in their blood, urine, and stool. The goal was to understand the drug's path and identify its main breakdown products, which helps design better future studies.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • The First Affiliated Hospital of Soochow University

    Suzhou, Jiangsu, 215006, China

Conditions

Explore the condition pages connected to this study.